Trial intelligence / Profile preview

Fluzone and Fluzone High-Dose 2011-2012 in Adults 65+

NCT01430819Phase 4Completed

Sponsor
Sanofi
Start
Sep 2011
Primary completion
Feb 2012
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of Fluzone Trivalent, trivalent inactivated influenza vaccine high-dose in influenza, sponsored by Sanofi. Started Sep 2011; status: completed.

02

Drugs

Fluzone Trivalenttrivalent inactivated influenza vaccine high-dose
03

Conditions

influenza

Beyond the preview

Go deeper on NCT01430819.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01430819.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call